Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Martin Tio"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
Abstract Background Early studies indicated that corticosteroids may limit the survival benefit from immunotherapy. We conducted this systematic review to evaluate the effect corticosteroids have on immunotherapy in patients with malignancy, when adj
Externí odkaz:
https://doaj.org/article/9f3f1ec0c82246868a29b1500c329c31
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 13, Iss , Pp 38-43 (2018)
Background and purpose: Malignant pleural mesothelioma (MPM) is an aggressive cancer with a propensity for seeding procedure tracts, leading to symptomatic metastases. There is conflicting evidence on the value of prophylactic procedure tract radioth
Externí odkaz:
https://doaj.org/article/3f1e6c654c1f466c8d7ba237f530ea68
Publikováno v:
Breast Cancer Research and Treatment. 178:135-140
Purpose Vulvovaginal atrophy (VVA) is a commonly reported issue among breast cancer patients, and its aetiology is multifactorial. Treatment is difficult in these women, particularly because the use of oestrogens has traditionally been discouraged. V
Autor:
Alexander M. Menzies, Melinda E. Sanders, Yan Liang, Elizabeth I. Buchbinder, Simon Mallal, Cody A. Chastain, Yu Wang, Akansha Chowdhary, Elisabeth J. Rushing, Daniel Y. Wang, Chanjuan Shi, Joseph M. Beechem, Meabh O'Hare, Bret C. Mobley, Amanda C. Guidon, Jeffrey A. Sosman, Justin M. Balko, Paula I. Gonzalez-Ericsson, Sarah Warren, Justine V. Cohen, Sunandana Chandra, Joe-Elie Salem, Javid Moslehi, Martin Tio, Kristi Barker, Simone M. Goldinger, Yaomin Xu, Douglas B. Johnson, Bénédicte Lebrun-Vignes, Rami N. Al-Rohil, Violeta Sanchez, Wyatt J. McDonnell, Georgina V. Long
Publikováno v:
Nature Medicine. 25:1243-1250
Checkpoint inhibitors produce durable responses in numerous metastatic cancers, but immune-related adverse events (irAEs) complicate and limit their benefit. IrAEs can affect organ systems idiosyncratically; presentations range from mild and self-lim
Autor:
Hyeong Cheon Park, Bak Leong Goh, Iain C. Macdougall, Vanessa Stevens, Martin Tio, Timothy Robert Cushway, Hui Lin Choong, Simon D. Roger
Publikováno v:
Nephrology (Carlton, Vic.)
Aim Higher dosages of erythropoiesis‐stimulating agents (ESAs) have been associated with adverse effects. Intravenous iron is used to optimize ESA response and reduces ESA doses in haemodialysis patients; this meta‐analysis evaluates the magnitud
Publikováno v:
Breast cancer research and treatment. 178(1)
Vulvovaginal atrophy (VVA) is a commonly reported issue among breast cancer patients, and its aetiology is multifactorial. Treatment is difficult in these women, particularly because the use of oestrogens has traditionally been discouraged. Vaginal l
Autor:
Douglas B, Johnson, Wyatt J, McDonnell, Paula I, Gonzalez-Ericsson, Rami N, Al-Rohil, Bret C, Mobley, Joe-Elie, Salem, Daniel Y, Wang, Violeta, Sanchez, Yu, Wang, Cody A, Chastain, Kristi, Barker, Yan, Liang, Sarah, Warren, Joseph M, Beechem, Alexander M, Menzies, Martin, Tio, Georgina V, Long, Justine V, Cohen, Amanda C, Guidon, Méabh, O'Hare, Sunandana, Chandra, Akansha, Chowdhary, Bénédicte, Lebrun-Vignes, Simone M, Goldinger, Elisabeth J, Rushing, Elizabeth I, Buchbinder, Simon A, Mallal, Chanjuan, Shi, Yaomin, Xu, Javid J, Moslehi, Melinda E, Sanders, Jeffrey A, Sosman, Justin M, Balko
Publikováno v:
Nature medicine
Checkpoint inhibitors produce durable responses in numerous metastatic cancers, but immune-related adverse events (irAEs) complicate and limit their benefit. IrAEs can affect organ systems idiosyncratically; presentations range from mild and self-lim
Autor:
Ralf Gutzmer, Claus Garbe, Hira Rizvi, Alisa Y. Kane, Luke Ardolino, Paolo A. Ascierto, Ogochukwu M. Ezeoke, Victoria Atkinson, Alexander M. Menzies, Jennifer L. McQuade, Matthew D. Hellmann, Lisa Zimmer, Simone M. Goldinger, Georgina V. Long, Lavinia Spain, Justine V. Cohen, Martin Tio, Michael Millward, Douglas B. Johnson, John J. Park, Rajat Rai, Desmond Yip, Chloe Khoo, Samra Turajlic, Anthony M. Joshua
Publikováno v:
Eur J Cancer
Background Anti-programmed cell death protein 1/programmed death ligand 1 (PD-1/PD-L1) immunotherapy is now routinely used to treat several cancers. Clinical trials have excluded several populations, including patients with solid organ transplant, HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ca2382f6383ee824a1796afdc859fe
https://europepmc.org/articles/PMC10176037/
https://europepmc.org/articles/PMC10176037/
Autor:
Brindha Shivalingam, Gerald B Fogarty, Alexander Guminski, Martin Tio, Alexander M. Menzies, Xuan Wang, Serigne Lo, Matteo S. Carlino, Angela Hong, Georgina V. Long
Publikováno v:
Pigment cellmelanoma research. 31(4)
Historically, the prognosis of patients with melanoma brain metastases is poor, with median overall survival (OS) of 4-6 months. Little is known of OS in the era of modern systemic therapies and local therapy with stereotactic radiosurgery (SRS) or s
Publikováno v:
Prostate Cancer and Prostatic Diseases. 17:213-219
There is conflicting evidence regarding the role of folate on the risk of developing prostate cancer. We performed a systematic review and quantitative meta-analysis of folate blood levels and folate intake, and the risk of prostate cancer. Four elec